Table 3 Characteristics of included studies in the third aim.

From: No relationship between the acromiohumeral distance and pain in adults with subacromial pain syndrome: a systematic review and meta-analysis

Author

Study design

Method of measuring AHD and types of interventions

Population type

Population characteristics

(Age: Mean ± SD years unless denoted)

Results (Mean ± SD mm)

Third aim

     

Akkaya

et al.59

Randomised control and single blinded study

US

Experimental group: Weighted pendulum exercise

Control group: Unweighted exercises

(4 weeks, 3 times daily)

General

Experimental group:

n = 18 (6 males)

Age: 42.9 ± 8.5

Pain duration: 7.2 ± 4.3 months

Control group:

n = 16 (5 males)

Age: 40.4 ± 9.4

Pain duration: 6.6 ± 4.1 months

Experimental group:

AHD in 0° shoulder abduction:

Pre:11.20 ± 2.30

Post: 11.10 ± 2.00

p = 0.887

AHD in 30° shoulder abduction:

Pre: 10.50 ± 1.90

Post: 10.60 ± 1.90

p = 0.257

AHD in 60° shoulder abduction:

Pre: 10.30 ± 1.90

Post: 10.50 ± 2.20

p = 0.571

Experimental group:

SPADI:

Pre: 62.0 ± 21.5

Post: 32.4 ± 18.7

p = 0.001*

VAS rest:

Pre: 2.4 ± 2.1

Post: 0.9 ± 1.2

p = 0.006*

Belley et al.60

Triple-blind randomised control trial

US

Experimental group:

Rehab program focused on sensorimotor training with a-tDCS treatment

Control group:

Rehab program focused on sensorimotor training with sham a-tDCS treatment

(6 weeks, 8 treatments with home exercises

General

Experimental group:

n = 20 (11 males)

Age: 44 ± 11.0

Pain duration: Not reported

Control group:

n = 20 (11 males)

Age: 47 ± 9.0

Pain duration: Not reported

Experimental group:

AHD in 0° shoulder abduction:

Pre: 10.80 ± 1.70

Post: 11.00 ± 1.40

p > 0.05

AHD in 45° shoulder abduction:

Pre: 8.90 ± 1.40

Post: 9.50 ± 1.50

p < 0.05*

AHD in 60° shoulder abduction:

Pre: 8.60 ± 1.40

Post: 9.30 ± 1.50

p < 0.05*

Experimental group:

DASH:

Pre: 33.0 ± 13.6

Post: 9.5 ± 9.6

p < 0.05* WORC(%):

Pre: 53.8 ± 18.1

Post: 89.7 ± 12.5

p < 0.05*

Boudreau et al.61 single blinded prospective RCT

US

Experimental: EMG-based co-activation of serratus anterior, trapezius, pectoralis major and latissimus dorsi muscles during rotator cuff strengthening program

Control: EMG-based rotator cuff strengthening program with no co-activation of serratus anterior, trapezius, pectoralis major and latissimus dorsi

(6 weeks, 7 days/wk)

General

Experimental group:

n = 21 (12 males)

Age: 50.2 ± 10.9

Pain duration: 44.2 ± 52.9 months

Control group:

n = 21 (8 males)

Age: 49.6 ± 13.2

Pain duration: 41.8 ± 40.5 months

Experimental group

AHD in 0° shoulder abduction:

Pre: 10.8 ± 2.1

Post: 11.5 ± 2.7

p = 0.56

AHD in 30° shoulder abduction:

Pre: 10.4 ± 2.3

Post: 10.6 ± 2.4

p = 0.44

AHD in 60° shoulder abduction:

Pre: 9.5 ± 2.7

Post: 9.8 ± 2.4

p = 0.75

Experimental group:

DASH:

Pre: 32.2 ± 15.4

Post: 27.8 ± 18.7

p > 0.211

WORC(%):

Pre: 51.6 ± 18.5

Post: 65.7 ± 25.8

p < 0.001*

VAS movement:

Pre: 71.1 ± 17.3

Post: 56.1 ± 29.6

p < 0.001*

Desmeules

et al.32

Pre-post treatment clinical trial, single group design

US

Experimental group:

Rehabilitation program involving education, ice, stretching, elastic band exercise for the rotator cuff, postural exercise, Maitland mobilisations, ST and GH control exercises

Control group:

None

(4 weeks, 12 sessions)

General

Experimental group:

n = 7 (gender not reported)

Age: 44 ± 3.8

Pain duration: 4–24 weeks

Correlation between the maximum change in AHD from shoulder abduction 0–60° with change in WORC%:

r = 0.84 p = 0.01*

 

Dupuis

et al.62

Parallel group RCT

US

Experimental group: Isometric rotator cuff exercises cryotherapy

Control group:

rest, ice, advice to avoid pain

(2 weeks)

General

Experimental group:

n = 20 (13 males)

Age: 33 ± 7

Pain duration: 27 ± 9 days

Control group:

n = 23 (11 males)

Age: 43 ± 13

Pain duration: 25 ± 7 days

Experimental group:

AHD in 0° shoulder abduction:

Pre:10 ± 2

Post: 10 ± 1

p > 0.11

AHD in 45° shoulder abduction:

Pre: 8 ± 2

Post: 8 ± 2

p > 0.11

AHD in 60° shoulder abduction:

Pre: 7 ± 2

Post: 7 ± 2

p > 0.11

Experimental group:

DASH:

Pre: 29.3 ± 12.6

Post: 16.3 ± 11.3

p < 0.05

WORC(%):

Pre: 55.7 ± 21.0

Post: 80.6 ± 17.1

p < 0.05

Savoie et al.29

Single group prospective

US

Experimental group:

Rehabilitation program involving

movement training, manual therapy, strengthening and stretching exercises,

and patient education

Control group:

None

(6 weeks)

General

Experimental group:

n = 25 (15 males)

Age: 42.6 ± 11.5

Pain duration: 99.3 ± 141.3 weeks

Experimental group:

AHD in 0° shoulder abduction:

Pre: 9.9 ± 2.0

Post: 10.4 ± 1.7

p > 0.05

AHD in 45° shoulder abduction:

Pre: 7.9 ± 2.2

Post: 8.8 ± 1.6

p < 0.05*

AHD in 60° shoulder abduction:

Pre: 7.5 ± 2.1

Post: 8.2 ± 1.7

p < 0.05*

Change in pain or disability in the experimental group:

DASH:

17.1 ± 12.4, p < 0.001*

WORC(%):

-30.1 ± 14.0, p < 0.001*

  1. *Indicates significant improvement (p < 0.05). Data provided by the author.
  2. N: number of participants; AHD: acromiohumeral distance (mm); a-tDCS: anodal transcranial direct current stimulation; CI: confidence interval; DASH: Disabilities of the Arm Shoulder and Hand questionnaire; GH: gleno-humeral; MRI: magnetic resonance imaging; NA: not applicable; OcR: Occupation ratio percentage; SAPS: subacromial pain syndrome; SIS: subacromial impingement syndrome; SPADI: Shoulder Pain and Disability Index; ST: scapulo-thoracic; STT: supraspinatus tendon thickness; RC: rotator cuff; RCRSP: rotator cuff related shoulder pain; RCT: rotator cuff tendinopathy; US: ultrasound; VAS: Visual Analogue Scale; WORC: Western Ontario Rotator Cuff index.